GlobalData
Ovarian cancer market set to smash $6.7 billion by 2025
October 28, 2019Sales and Marketing Cancer, GlobalData, ovarian cancer, pharma
New research from GlobalData has forecast that the worldwide market for ovarian cancer is set to expand at a compound …
Healthcare industry could take up to five years to stabilise after no-deal Brexit
March 13, 2019Manufacturing and Production, Medical Communications, Research and Development GlobalData, analysis, brexit, no-deal Brexit, surveys
The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to …
Heart failure market to quadruple in ten years to $16 billion
July 6, 2017Sales and Marketing GlobalData, Novartis, heart failure
New research from intelligence firm GlobalData has indicated that the market for heart failure drugs is forecast to expand by …
Non-small cell lung cancer market to hit $26bn by 2025
November 24, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GlobalData, non-small cell lung cancer
New research from GlobalData has indicated that the non-small cell lung cancer (NSCLC) market will rise in value by over …
UAE’s pharmaceutical market projected to grow from $3 billion to $5.7 billion by 2020
October 10, 2016Manufacturing and Production Abu Dhabi, Dubai, GlobalData, United Arab Emires, growth, medical tourism, pharmaceutical market
United Arab Emirates’ pharmaceutical market is set for growth of 13% annually to reach $5.7 billion by 2020, up from …
Acute coronary syndrome market to grow to over $12 billion by 2022
August 15, 2016Research and Development, Sales and Marketing GlobalData, acute coronary syndrome
The acute coronary syndrome (ACS) market is forecast to rise from $7.8 billion in 2015 to $12.1 billion by 2022 …
EU referendum outcome will have major consequences for UK’s pharma sector – GlobalData
June 23, 2016Medical Communications, Sales and Marketing EMA, GlobalData, Pharma sector, brexit, referendum
The outcome of today’s referendum on the UK’s continuing membership of the European Union (EU) will have major consequences for …
Indian pharma market set to grow to $55 billion by 2020
January 28, 2016Sales and Marketing GlobalData
The pharmaceuticals market in India, valued at $20 billion in 2015, is set to soar to $55 billion by 2020, …
Pharma deals crucial to cutting R&D costs
December 16, 2015Research and Development GlobalData, R&D, drug development, pharma, research and development
With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …
Lung cancer market to hit $10.9bn by 2021
September 10, 2015Sales and Marketing AZD9291, GBI Research, GlobalData, NSCLC, industry analysis, industry intelligence, industry reports, keytruda, market intelligence lung cancer, market reports, market trends, non small cell lung cancer, non-small cell lung cancer, opdivo, world conference on lung cancer
The global market value for non-small cell lung cancer treatment will rise from $6.9 billion in 2014 to $10.9 billion …
Type 1 diabetes market value to double by 2023
March 19, 2015Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1
The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …
Pharma to profit from Obama reforms
March 18, 2015Sales and Marketing FDA, GlobalData, Obama, US, healthcare, insurance
President Obama’s healthcare reforms will drive massive growth in the US pharma market a new report is predicting. The size …
Pharma to lose $69 billion in five years as patents expire
December 12, 2014Sales and Marketing AstraZeneca, GlobalData, Japanese firm Otsuka, Otsuka, lilly, pharma
Pharma companies are set to lose around $65 billion by 2019 due to drug patent expiries according to research firm …
Pharma R&D ‘untenable’
April 25, 2013Research and Development, Sales and Marketing GlobalData, R&D
The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …
